Resistance to penicillin among the Streptococcus pneumoniae in Turkey

Yurdakul A.S., Calisir H.C., Atasever M., Ordulu L., Ogretensoy M.

Source: Eur Respir J 2001; 18: 436
Journal Issue: August
Disease area: Respiratory infections

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yurdakul A.S., Calisir H.C., Atasever M., Ordulu L., Ogretensoy M.. Resistance to penicillin among the Streptococcus pneumoniae in Turkey. Eur Respir J 2001; 18: 436

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Emergence of penicillin resistant Streptococcus pneumoniae in Pakistan
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005

Resistance of Streptococcus pneumoniae to penicillin, azitromycin, ciprofloxacyn and ceftriaxon
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001

Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae
Source: Eur Respir J 2006; 27: 1020-1025
Year: 2006



CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Prevalence of penicillin-resistant streptococcus pneumoniae in two community hospitals in Japan
Source: Eur Respir J 2007; 30: Suppl. 51, 409s
Year: 2007

Evaluation of macrolide resistance of streptococcus pneumoniae in southern Brazil
Source: Eur Respir J 2004; 24: Suppl. 48, 188s
Year: 2004

Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001

Increasing global resistance to penicillin, macrolides and other antimicrobials among isolates of Streptococcus pneumoniae: susceptibility data from three years of the PROTEKT surveillance study
Source: Eur Respir J 2003; 22: Suppl. 45, 486s
Year: 2003

Resistance of respiratory tract Streptococcus pneumoniae strains
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002

Surveillance of antibiotic resistance in Streptococcus pneumoniae from 2000 to 2011 and serogroup distribution in Tunisia
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012


Quinolones consume and streptococcus pneumoniae antibiotic resistance
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Penicillin-resistance in Streptococcus pneumoniae isolates among adults with community-acquired pneumonia in the region of Tarragona, Spain
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008


Streptococcus pneumoniae antibiotic resistance from 1986 to 2004
Source: Eur Respir J 2005; 26: Suppl. 49, 640s
Year: 2005

Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia
Source: Eur Respir J 2010; 36: 969-971
Year: 2010


Levofloxacin resistance among streptococcus pneumoniae isolates in a chronic disease hospital
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010


Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis
Source: Eur Respir J 2007; 29: 1127-1137
Year: 2007



Treatment challenges in methicillin resistant Staphylococcus aureus infections
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009



Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections
Source: Eur Respir J 2002; 20: 3S-8S
Year: 2002



Genetic Analyses of Multidrug-Resistant Streptococcus pneumoniae Serogroup 19 CC320/271 Clone in China
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017